Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
- Conditions
- Acute Lymphoblastic Leukemia
- Registration Number
- NCT04928599
- Lead Sponsor
- Children's Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria:<br><br> - All Children's Oncology Group (COG) NCI Community Oncology Research Program<br> (National Cancer Institute [N]CORP) institutions are eligible for participation in<br> this study upon first parent enrollment<br><br> - Parents of an index child who meets the following characteristics are eligible for<br> this study:<br><br> - Index child must be newly diagnosed with de novo ALL<br><br> - Index child must be between the ages of 1 and 14.9 years at the time of the<br> parent's enrollment<br><br> - At the parent's entry to the study, the index child must be receiving induction<br> chemotherapy for newly diagnosed ALL at the enrolling institution. The index<br> child may be enrolled in therapeutic clinical ALL trials or receiving ALL<br> therapy per standard of care<br><br> - Parents age 18 years and above are eligible for this study<br><br> - Parent must speak English or Spanish in order to participate in the consent process<br> and provide consent. The parent's language skills must be sufficient to understand<br> the study requirements and complete the survey and interview questions<br><br> - At the parent's entry to the study, the index child must be receiving induction<br> chemotherapy for newly diagnosed ALL at the enrolling institution. The index child<br> may be enrolled in therapeutic clinical ALL trials or receiving ALL therapy per<br> standard of care<br><br> - REGULARTORY REQUIREMENTS: All parents must sign a written informed consent for their<br> participation in the study<br><br> - REGULARTORY REQUIREMENTS: All institutional and NCI requirements for human studies<br> must be met<br><br>Exclusion Criteria:<br><br> - Parents of index children with any of the following clinical characteristics will be<br> excluded from the study:<br><br> - KMT2A-R (formerly MLL-R) not receiving ALL therapy<br><br> - Mixed-phenotype acute leukemia (MPAL) not receiving ALL therapy<br><br> - Burkitt's leukemia
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in financial distress
- Secondary Outcome Measures
Name Time Method Factors associated with financial distress